Pestigon 134 mg Spot-On Solution for Medium Dogs

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Viambatanisho vya kazi:

Fipronil

Inapatikana kutoka:

Norbrook Laboratories (Ireland) Limited

ATC kanuni:

QP53AX15

INN (Jina la Kimataifa):

Fipronil

Kipimo:

134 mg/pipette

Dawa fomu:

Spot-on solution

Dawa ya aina:

POM: Prescription Only Medicine as defined in relevant national legislation

Eneo la matibabu:

fipronil

Idhini hali ya:

Authorised

Idhini ya tarehe:

2012-07-06

Tabia za bidhaa

Health Products Regulatory Authority
27 February 2019
CRN008THN
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Pestigon 134 mg Spot-On Solution for Medium Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One 1.34 ml pipette contains:
ACTIVE SUBSTANCE:
Fipronil 134 mg
EXCIPIENTS:
Butylhydroxyanisole (E320) 0.268 mg
Butylhydroxytoluene (E321) 0.134 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
A clear, colourless to pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infestations by fleas (_Ctenocephalidesfelis_).
The product shows immediate insecticidal effect and persistent
insecticidal activity against new infestations by adult fleas for up
to 8 weeks.
The product has a persistent acaricidal efficacy against _Ixodes
ricinus_ for up to 2 weeks, _Rhipicephalus sanguineus_ for up to 3
weeks and _Dermacentor reticulatus_ for up to 4 weeks. If ticks of
these species are present when the product is applied, all ticks
will not be killed within the first 48 hours but they may be killed
within a week.
The product can be used as part of a treatment programme for Flea
Allergy Dermatitis where this has been previously
diagnosed by a Veterinary Surgeon.
4.3 CONTRAINDICATIONS
Do not use in dogs weighing less than 10 kg.
In the absence of available data, the product should not be used in
puppies less than 8 weeks old.
Do not use in sick (systemic diseases, fever…) or convalescent
animals.
Do not use in rabbits, as adverse reactions and even death could
occur.
This product is specifically developed for dogs. Do not use in cats,
as this could lead to overdosing.
Do not use in cases of known hypersensitivity to the active or to any
of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Health Products Regulatory Authority
27 February 2019
CRN008THN
Page 2 of 7
The product does not prevent ticks from attaching to the animals, but
ticks may